Lazard (LAZ) Competitors $54.31 +0.15 (+0.28%) Closing price 07/18/2025 03:59 PM EasternExtended Trading$54.34 +0.02 (+0.05%) As of 07/18/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock LAZ vs. AMP, EQH, EVR, GS, JEF, JHG, MC, MS, PIPR, and SFShould you be buying Lazard stock or one of its competitors? The main competitors of Lazard include Ameriprise Financial (AMP), Equitable (EQH), Evercore (EVR), The Goldman Sachs Group (GS), Jefferies Financial Group (JEF), Janus Henderson Group (JHG), Moelis & Company (MC), Morgan Stanley (MS), Piper Sandler Companies (PIPR), and Stifel Financial (SF). These companies are all part of the "finance" sector. Lazard vs. Its Competitors Ameriprise Financial Equitable Evercore The Goldman Sachs Group Jefferies Financial Group Janus Henderson Group Moelis & Company Morgan Stanley Piper Sandler Companies Stifel Financial Lazard (NYSE:LAZ) and Ameriprise Financial (NYSE:AMP) are both finance companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, dividends, analyst recommendations, valuation, earnings and media sentiment. Do analysts recommend LAZ or AMP? Lazard presently has a consensus price target of $51.00, suggesting a potential downside of 6.09%. Ameriprise Financial has a consensus price target of $524.71, suggesting a potential downside of 3.63%. Given Ameriprise Financial's stronger consensus rating and higher probable upside, analysts clearly believe Ameriprise Financial is more favorable than Lazard.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Lazard 2 Sell rating(s) 4 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.00Ameriprise Financial 2 Sell rating(s) 3 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.14 Do institutionals and insiders hold more shares of LAZ or AMP? 54.8% of Lazard shares are held by institutional investors. Comparatively, 84.0% of Ameriprise Financial shares are held by institutional investors. 3.9% of Lazard shares are held by insiders. Comparatively, 0.7% of Ameriprise Financial shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Which has more volatility & risk, LAZ or AMP? Lazard has a beta of 1.33, meaning that its stock price is 33% more volatile than the S&P 500. Comparatively, Ameriprise Financial has a beta of 1.23, meaning that its stock price is 23% more volatile than the S&P 500. Does the media refer more to LAZ or AMP? In the previous week, Lazard had 5 more articles in the media than Ameriprise Financial. MarketBeat recorded 27 mentions for Lazard and 22 mentions for Ameriprise Financial. Ameriprise Financial's average media sentiment score of 0.98 beat Lazard's score of 0.60 indicating that Ameriprise Financial is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Lazard 9 Very Positive mention(s) 5 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Ameriprise Financial 15 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Is LAZ or AMP more profitable? Ameriprise Financial has a net margin of 17.14% compared to Lazard's net margin of 10.15%. Ameriprise Financial's return on equity of 68.93% beat Lazard's return on equity.Company Net Margins Return on Equity Return on Assets Lazard10.15% 37.64% 5.18% Ameriprise Financial 17.14%68.93%2.03% Which has preferable earnings & valuation, LAZ or AMP? Ameriprise Financial has higher revenue and earnings than Lazard. Ameriprise Financial is trading at a lower price-to-earnings ratio than Lazard, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLazard$3.05B2.01$279.91M$2.8718.92Ameriprise Financial$17.26B3.00$3.40B$29.4318.50 Is LAZ or AMP a better dividend stock? Lazard pays an annual dividend of $2.00 per share and has a dividend yield of 3.7%. Ameriprise Financial pays an annual dividend of $6.40 per share and has a dividend yield of 1.2%. Lazard pays out 69.7% of its earnings in the form of a dividend. Ameriprise Financial pays out 21.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Ameriprise Financial has raised its dividend for 21 consecutive years. SummaryAmeriprise Financial beats Lazard on 13 of the 20 factors compared between the two stocks. Get Lazard News Delivered to You Automatically Sign up to receive the latest news and ratings for LAZ and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LAZ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LAZ vs. The Competition Export to ExcelMetricLazardFIN IndustryFinance SectorNYSE ExchangeMarket Cap$6.11B$7.91B$12.16B$20.82BDividend Yield3.69%4.78%5.56%3.65%P/E Ratio18.9218.9619.1727.58Price / Sales2.016.7026.4458.71Price / Cash8.3823.0821.6822.29Price / Book8.932.862.314.66Net Income$279.91M$308.89M$997.60M$995.72M7 Day Performance4.46%7.57%0.63%-0.30%1 Month Performance24.65%22.22%4.61%4.90%1 Year Performance21.23%25.89%538.47%11.14% Lazard Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LAZLazard4.643 of 5 stars$54.31+0.3%$51.00-6.1%+20.7%$6.11B$3.05B18.923,263Trending NewsUpcoming EarningsAnalyst RevisionAMPAmeriprise Financial4.2863 of 5 stars$536.13-1.3%$517.86-3.4%+30.3%$51.05B$17.47B18.2213,600Positive NewsUpcoming EarningsAnalyst DowngradeEQHEquitable4.2984 of 5 stars$54.62-1.9%$62.64+14.7%+25.8%$16.60B$12.44B14.848,000Positive NewsInsider TradeEVREvercore4.3725 of 5 stars$283.79-1.3%$255.14-10.1%+23.5%$11.10B$2.98B27.162,380Analyst RevisionGSThe Goldman Sachs Group4.8809 of 5 stars$710.58-1.8%$603.73-15.0%+45.7%$218.03B$126.85B16.4946,500Trending NewsEarnings ReportDividend IncreaseAnalyst ForecastJEFJefferies Financial Group4.4972 of 5 stars$55.60-2.4%$66.00+18.7%+2.7%$11.47B$10.41B20.987,822Trending NewsJHGJanus Henderson Group4.4911 of 5 stars$39.97-0.8%$43.11+7.9%+17.4%$6.30B$2.47B15.862,300Analyst ForecastMCMoelis & Company2.728 of 5 stars$65.54-0.4%$64.17-2.1%+8.1%$5.15B$1.19B30.061,309News CoverageUpcoming EarningsAnalyst RevisionMSMorgan Stanley4.7906 of 5 stars$143.76-0.3%$133.62-7.1%+34.4%$230.64B$59.92B16.8780,000Trending NewsEarnings ReportDividend IncreaseInsider TradePIPRPiper Sandler CompaniesN/A$288.58-1.7%$286.00-0.9%N/A$5.13B$1.53B25.231,805SFStifel Financial4.0005 of 5 stars$107.54-1.5%$106.75-0.7%+32.5%$11.05B$4.97B20.569,000Upcoming Earnings Related Companies and Tools Related Companies AMP Competitors EQH Competitors EVR Competitors GS Competitors JEF Competitors JHG Competitors MC Competitors MS Competitors PIPR Competitors SF Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:LAZ) was last updated on 7/19/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lazard, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lazard With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
